Population
243 patients with pathologically verified primary osteosarcomas of bone treated at The University of Texas…
Design
Cohort
Follow-up
5 years
Authors
Loading...
Historical cohort confirms poor pre-adjuvant osteosarcoma survival; leaves open impact of contemporary multimodal regimens.
Prior to the use of adjuvant chemotherapy, primary osteosarcoma of bone had a poor prognosis with a 5-year survival rate of only 12.6%.
Uribe-Botero et al. (1977) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: